Filing Details
- Accession Number:
- 0001209191-12-008179
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-07 16:53:24
- Reporting Period:
- 2012-02-03
- Filing Date:
- 2012-02-07
- Accepted Time:
- 2012-02-07 16:53:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1009356 | Salix Pharmaceuticals Ltd | SLXP | Pharmaceutical Preparations (2834) | 943267443 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1314760 | P William Forbes | 8510 Colonnade Center Drive Raleigh NC 27615 | Evp Research&Devel & Cdo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-02-03 | 259 | $17.53 | 55,896 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-02-03 | 259 | $50.00 | 55,637 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to Buy Common Stock | Disposition | 2012-02-03 | 259 | $0.00 | 259 | $17.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 58,497 | 2014-12-16 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to Buy Common Stock | $17.63 | 2015-06-09 | 6,250 | 6,250 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2015-06-09 | 6,250 | 6,250 | Direct |
Footnotes
- The shares covered by this Form 4 have been sold pursuant to a Rule 10b5-1 Sales Plan dated December 7, 2011, which is intended to comply with Rule 10b5-1.
- Options are 100% vested.
Billionaire Hedge Funds
